ArticlePediatric blood & cancer2018

Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program.

Raushan T Kurmasheva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.